These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22227664)

  • 1. Tumor strengths and frailties: Cancer SUMmOns Otto's metabolism.
    Ohh M
    Nat Med; 2012 Jan; 18(1):30-1. PubMed ID: 22227664
    [No Abstract]   [Full Text] [Related]  

  • 2. [MITF: a genetic key to melanoma and renal cell carcinoma?].
    Bertolotto C; Lesueur F; Bressac de Paillerets B
    Med Sci (Paris); 2012 Mar; 28(3):258-61. PubMed ID: 22480646
    [No Abstract]   [Full Text] [Related]  

  • 3. A germline oncogenic MITF mutation and tumor susceptibility.
    Paillerets BB; Lesueur F; Bertolotto C
    Eur J Cell Biol; 2014; 93(1-2):71-5. PubMed ID: 24290354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyses of the transcriptome and metabolome demonstrate that HIF1α mediates altered tumor metabolism in clear cell renal cell carcinoma.
    Minton DR; Fu L; Chen Q; Robinson BD; Gross SS; Nanus DM; Gudas LJ
    PLoS One; 2015; 10(4):e0120649. PubMed ID: 25830305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microphthalmia-associated transcription factor, melanoma, and renal carcinoma: the small ubiquitin-like modifier connection.
    Yeh ET
    Pigment Cell Melanoma Res; 2011 Dec; 24(6):1079-80. PubMed ID: 22216437
    [No Abstract]   [Full Text] [Related]  

  • 6. MITF pathway mutations in melanoma.
    Yokoyama S; Salma N; Fisher DE
    Pigment Cell Melanoma Res; 2009 Aug; 22(4):376-7. PubMed ID: 19558635
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of mitochondrial respiration with auraptene inhibits the progression of renal cell carcinoma: involvement of HIF-1α degradation.
    Jang Y; Han J; Kim SJ; Kim J; Lee MJ; Jeong S; Ryu MJ; Seo KS; Choi SY; Shong M; Lim K; Heo JY; Kweon GR
    Oncotarget; 2015 Nov; 6(35):38127-38. PubMed ID: 26474388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappaB is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure.
    Konda R; Sugimura J; Sohma F; Katagiri T; Nakamura Y; Fujioka T
    J Urol; 2008 Aug; 180(2):481-5. PubMed ID: 18550099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
    Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
    BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster Delivery.
    Saxena N; Maio N; Crooks DR; Ricketts CJ; Yang Y; Wei MH; Fan TW; Lane AN; Sourbier C; Singh A; Killian JK; Meltzer PS; Vocke CD; Rouault TA; Linehan WM
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26719882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal carcinoma with giant mitochondria associated with germ-line mutation and somatic loss of the succinate dehydrogenase B gene.
    Housley SL; Lindsay RS; Young B; McConachie M; Mechan D; Baty D; Christie L; Rahilly M; Qureshi K; Fleming S
    Histopathology; 2010 Feb; 56(3):405-8. PubMed ID: 20459544
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability.
    Lehtonen HJ; Mäkinen MJ; Kiuru M; Laiho P; Herva R; van Minderhout I; Hogendoorn PC; Cornelisse C; Devilee P; Launonen V; Aaltonen LA
    Int J Cancer; 2007 Sep; 121(6):1386-9. PubMed ID: 17520677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
    Bertolotto C; Lesueur F; Giuliano S; Strub T; de Lichy M; Bille K; Dessen P; d'Hayer B; Mohamdi H; Remenieras A; Maubec E; de la Fouchardière A; Molinié V; Vabres P; Dalle S; Poulalhon N; Martin-Denavit T; Thomas L; Andry-Benzaquen P; Dupin N; Boitier F; Rossi A; Perrot JL; Labeille B; Robert C; Escudier B; Caron O; Brugières L; Saule S; Gardie B; Gad S; Richard S; Couturier J; Teh BT; Ghiorzo P; Pastorino L; Puig S; Badenas C; Olsson H; Ingvar C; Rouleau E; Lidereau R; Bahadoran P; Vielh P; Corda E; Blanché H; Zelenika D; Galan P; ; Aubin F; Bachollet B; Becuwe C; Berthet P; Bignon YJ; Bonadona V; Bonafe JL; Bonnet-Dupeyron MN; Cambazard F; Chevrant-Breton J; Coupier I; Dalac S; Demange L; d'Incan M; Dugast C; Faivre L; Vincent-Fétita L; Gauthier-Villars M; Gilbert B; Grange F; Grob JJ; Humbert P; Janin N; Joly P; Kerob D; Lasset C; Leroux D; Levang J; Limacher JM; Livideanu C; Longy M; Lortholary A; Stoppa-Lyonnet D; Mansard S; Mansuy L; Marrou K; Matéus C; Maugard C; Meyer N; Nogues C; Souteyrand P; Venat-Bouvet L; Zattara H; Chaudru V; Lenoir GM; Lathrop M; Davidson I; Avril MF; Demenais F; Ballotti R; Bressac-de Paillerets B
    Nature; 2011 Oct; 480(7375):94-8. PubMed ID: 22012259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4.
    Gill AJ; Pachter NS; Clarkson A; Tucker KM; Winship IM; Benn DE; Robinson BG; Clifton-Bligh RJ
    N Engl J Med; 2011 Mar; 364(9):885-6. PubMed ID: 21366490
    [No Abstract]   [Full Text] [Related]  

  • 15. SDHB--a gene for all tumors?
    Eng C
    J Natl Cancer Inst; 2008 Sep; 100(17):1193-5. PubMed ID: 18728280
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tumor suppressor gene VHL, hypoxia inducible factor, and renal cell carcinoma].
    Zhang YT; Chen N; Zeng H; Zhou Q
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):562-4. PubMed ID: 17134554
    [No Abstract]   [Full Text] [Related]  

  • 17. Signalling pathways in succinate dehydrogenase B-associated renal carcinoma.
    Fleming S; Mayer NJ; Vlatkovic LJ; McLean J; McConachie M; Baty D
    Histopathology; 2014 Mar; 64(4):477-83. PubMed ID: 24236567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myoglobin expression in renal cell carcinoma is regulated by hypoxia.
    Behnes CL; Bedke J; Schneider S; Küffer S; Strauss A; Bremmer F; Ströbel P; Radzun HJ
    Exp Mol Pathol; 2013 Dec; 95(3):307-12. PubMed ID: 24076247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.
    Steunou AL; Ducoux-Petit M; Lazar I; Monsarrat B; Erard M; Muller C; Clottes E; Burlet-Schiltz O; Nieto L
    Mol Cell Proteomics; 2013 Mar; 12(3):736-48. PubMed ID: 23275444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
    Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.